Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

This study has been completed.
Information provided by (Responsible Party):
QLT Inc. Identifier:
First received: February 9, 2004
Last updated: May 22, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2005
  Primary Completion Date: May 2005 (Final data collection date for primary outcome measure)